Phase II, Multi-Center, Randomized, Double-Blind Study of Nitazoxanide Tablets Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Chronic Hepatitis C

NCT00418054 Phase 2 COMPLETED

The purpose of this study is to evaluate the safety and efficacy of nitazoxanide-peginterferon alfa-2b combination therapy compared to peginterferon monotherapy in patients that are treatment naive or pre-treated for 24 weeks with nitazoxanide monotherapy in the treatment of chronic hepatitis C.

Details

Lead sponsor	Romark Laboratories L.C.
Phase	Phase 2
Status	COMPLETED
Enrolment	40
Start date	2005-12
Completion	2006-07

Conditions

• Chronic Hepatitis C

Interventions

• Nitazoxanide plus peginterferon alfa-2b
• Peginterferon alfa-2b

Primary outcomes

• Virologic response

Countries

Egypt